Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Hansen (HNSN) -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (2)	12/26/2006 8:55:13 AM
From: Arthur Radley	Read Replies (1) \| Respond to of 8

Dec 26 (Reuters) - J.P. Morgan Securities started coverage of medical robotics company Hansen Medical Inc. (HNSN.O: Quote, Profile , Research) with an "overweight" rating. The brokerage said Hansen's Sensei robotic remote catheter navigation system has the potential to be a platform technology in the cath lab with applicability across a wide range of interventional procedures. While the company is still early in its development efforts, the stock is attractive at current levels, particularly for those with longer investment horizons, J.P Morgan said.